Back to User profile » Dr Nengming Lin
Papers published by Dr Nengming Lin:
Clinical Trial Report
Pharmacokinetics, Safety and Tolerability of HPP737, a Novel PDE4 Inhibitor, in Healthy Chinese Participants: Phase I Study
Ye L, Wang L, Tao X, Cai S, Lin N, Li Y, Zhu Q, Zhu Q, Wang F
Drug Design, Development and Therapy 2026, 20:598997
Published Date: 19 May 2026
Original Research
Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection
Zhang R, Fan J, Han L, Mao J, Sun L, Yu Y, Fan W, Xie J, Lin B, Lin N
Drug Design, Development and Therapy 2024, 18:5517-5527
Published Date: 2 December 2024
Review
Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical
Dong R, Yan Y, Zeng X, Lin N, Tan B
Drug Design, Development and Therapy 2022, 16:3225-3239
Published Date: 20 September 2022